nicardipine aguettant 10 mg/10 ml sol. inj. i.v. amp.
laboratoire aguettant - chlorhydrate de nicardipine 10 mg/10 ml - solution injectable - 10 mg/10 ml - chlorhydrate de nicardipine 1 mg/ml - nicardipine
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
paxlovid comprimés pelliculés
pfizer ag - nirmatrelvirum, ritonavirum - comprimés pelliculés - a): nirmatrelvirum 150 mg, cellulosum microcristallinum, lactosum monohydricum 185 mg, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, Überzug: hypromellosum, e 171, macrogolum 400, e 172 (rubrum), pro compresso obducto corresp. natrium 0.99 mg. b): ritonavirum 100 mg, copovidonum, silica colloidalis anhydrica, sorbitani lauras, calcii hydrogenophosphas, natrii stearylis fumaras, Überzug: hypromellosum, e 171, macrogolum 400, macrogolum 3350, hydroxypropylcellulosum, talcum, silica colloidalis anhydrica, polysorbatum 80, pro compresso obducto, natrium 0.388 mg. - behandlung von covid-19 - synthetika
urorec 4 mg 30 càpsules
urorec 8 mg 30 càpsules
silodyx 4 mg 30 càpsules
silodyx 8 mg 30 càpsules
silodyx bcnfarma 8 mg 30 càpsules
urorec mediwin limited 8 mg 30 càpsules
silodyx euromedicines 4 mg 30 càpsules